Screening for Alzheimer’s disease in the community using an AI-driven screening platform: design of the PREDICTOM study

PREDICTOM will develop AI-driven algorithms for the early detection of AD using biomarkers that can be collected at home or in the community care setting, and evaluate their integration into a well-defined and comprehensive clinical pathway.